- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00735579
Wound Healing Abnormalities in Major Abdominal Surgery (INWOUND)
April 21, 2017 updated by: Armin Sablotzki, MD, Klinikum St. Georg gGmbH
Incidence of Wound-healing-abnormalities in Major Abdominal Surgery - Association With Factors of Coagulation
This clinical observational study investigates the incidence of wound healing abnormalities in patients undergoing major abdominal surgery.
Second aim of the study is, if wound healing deficits may be accompanied by abnormalities in blood coagulation parameters.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
260
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04105
- Klinikum St. Georg gGmbH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients undergoing major abdominal surgery
Description
Inclusion Criteria:
- Age >= 18 years
- Male or female
- Informed consent
- Major abdominal surgery
Exclusion Criteria:
- Pre-existing coagulation abnormalities
- Pre-existing severe renal or liver failure
- Chemo- or radiochemotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Study group
Patients undergoing major abdominal surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of wound healing abnormalities
Time Frame: from baseline to postoperative day 28
|
Occurence of wound healing abnormalities within the first 28 days after surgery
|
from baseline to postoperative day 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abnormalities in coagulation parameters
Time Frame: postoperative day 28
|
occurence of low platelets (<60.000) or factor XIII < 50% between the first and seventh postoperative day
|
postoperative day 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Armin R Sablotzki, MD, Klinikum St. Georg gGmbH
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
April 21, 2017
Study Completion (Actual)
April 21, 2017
Study Registration Dates
First Submitted
August 14, 2008
First Submitted That Met QC Criteria
August 14, 2008
First Posted (Estimate)
August 15, 2008
Study Record Updates
Last Update Posted (Actual)
April 24, 2017
Last Update Submitted That Met QC Criteria
April 21, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK-BR-21/08-1
- Stu08/0022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impaired Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Massachusetts General HospitalMomelan TechnologiesTerminatedImpaired Wound HealingUnited States
-
Carilion ClinicSmith & Nephew, Inc.; DeRoyal Industries, Inc.CompletedImpaired Wound Healing | Postoperative Wound Infection-deepUnited States
-
HealthpointCompleted
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
-
University Hospital, GhentCompleted
-
Dow University of Health SciencesUnknown